Leboeuf R - Search Results

1

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Ho AL, Grewal RK, Leboeuf R, Sherman EJ, Pfister DG, Deandreis D, Pentlow KS, Zanzonico PB, Haque S, Gavane S, Ghossein RA, Ricarte-Filho JC, Domínguez JM, Shen R, Tuttle RM, Larson SM, Fagin JA. Ho AL, et al. Among authors: leboeuf r. N Engl J Med. 2013 Feb 14;368(7):623-32. doi: 10.1056/NEJMoa1209288. N Engl J Med. 2013. PMID: 23406027 Free PMC article. Clinical Trial.

2

Investigational therapies for metastatic thyroid carcinoma.

Tuttle RM, Leboeuf R. Tuttle RM, et al. Among authors: leboeuf r. J Natl Compr Canc Netw. 2007 Jul;5(6):641-6. doi: 10.6004/jnccn.2007.0055. J Natl Compr Canc Netw. 2007. PMID: 17623615 Review.

3

Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.

Tuttle RM, Leboeuf R, Robbins RJ, Qualey R, Pentlow K, Larson SM, Chan CY. Tuttle RM, et al. Among authors: leboeuf r. J Nucl Med. 2006 Oct;47(10):1587-91. J Nucl Med. 2006. PMID: 17015892 Free article.

4

Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors.

Leboeuf R, Emerick LE, Martorella AJ, Tuttle RM. Leboeuf R, et al. Thyroid. 2007 Jun;17(6):543-7. doi: 10.1089/thy.2007.0020. Thyroid. 2007. PMID: 17614775

5

Papillary thyroid cancer: monitoring and therapy.

Tuttle RM, Leboeuf R, Martorella AJ. Tuttle RM, et al. Among authors: leboeuf r. Endocrinol Metab Clin North Am. 2007 Sep;36(3):753-78, vii. doi: 10.1016/j.ecl.2007.04.004. Endocrinol Metab Clin North Am. 2007. PMID: 17673127 Review.

6

Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.

Ghossein RA, Leboeuf R, Patel KN, Rivera M, Katabi N, Carlson DL, Tallini G, Shaha A, Singh B, Tuttle RM. Ghossein RA, et al. Among authors: leboeuf r. Thyroid. 2007 Jul;17(7):655-61. doi: 10.1089/thy.2007.0061. Thyroid. 2007. PMID: 17696836

7

Medical management of thyroid cancer: a risk adapted approach.

Tuttle RM, Leboeuf R, Shaha AR. Tuttle RM, et al. Among authors: leboeuf r. J Surg Oncol. 2008 Jun 15;97(8):712-6. doi: 10.1002/jso.21010. J Surg Oncol. 2008. PMID: 18493922 Review.

8

Follow up approaches in thyroid cancer: a risk adapted paradigm.

Tuttle RM, Leboeuf R. Tuttle RM, et al. Among authors: leboeuf r. Endocrinol Metab Clin North Am. 2008 Jun;37(2):419-35, ix-x. doi: 10.1016/j.ecl.2008.02.008. Endocrinol Metab Clin North Am. 2008. PMID: 18502335 Review.

9

Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.

Tuttle RM, Lopez N, Leboeuf R, Minkowitz SM, Grewal R, Brokhin M, Omry G, Larson S. Tuttle RM, et al. Among authors: leboeuf r. Thyroid. 2010 Mar;20(3):257-63. doi: 10.1089/thy.2009.0401. Thyroid. 2010. PMID: 20187781

10

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A. Tuttle RM, et al. Among authors: leboeuf r. Thyroid. 2010 Dec;20(12):1341-9. doi: 10.1089/thy.2010.0178. Epub 2010 Oct 29. Thyroid. 2010. PMID: 21034228 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters